What happens when groundbreaking cancer research threatens the status quo?
In this episode, Dr. Dan Rubin sits down with Sylvie Beljanski—author, lawyer, and daughter of the late Dr. Mirko Beljanski—to uncover a powerful story of scientific discovery, political suppression, and resilience.
Sylvie shares how her father's innovative research into plant-based compounds that selectively target cancer cells was nearly lost forever.
From the shocking arrest of her parents to rebuilding the research through the Beljanski Foundation, this conversation dives into science, courage, and legacy—plus the latest clinical trials exploring stem cells, RNA fragments, and natural compounds with profound potential in integrative oncology.
Topics covered include:
Her father's early discovery of DNA destabilization and environmental carcinogens
Natural compounds that target cancer cells without harming healthy cells
Research on ovarian, prostate, pancreatic, and breast cancer stem cells
Clinical trials on RNA extracts that support bone marrow during chemotherapy
Building the Beljanski Foundation and honoring a legacy
Chapters
00:00 – Introduction
01:00 – Sylvie’s legal background & the call that changed everything
04:00 – Her father's discovery: DNA destabilization and cancer
07:00 – Plant extracts that selectively inhibit cancer cell replication
09:00 – Mitterrand’s prostate cancer recovery
11:00 – Rebuilding the science in the U.S.
13:00 – Clinical insights with Columbia University & CTCA
17:30 – Cancer stem cells: the next frontier
19:00 – Golden ginkgo extract & angiogenesis
21:00 – RNA fragments for immune support during chemotherapy
23:30 – Clinical trials and collaborative research
24:30 – The power of community and legacy
26:00 – Where to find Sylvie and her work
🌐 Learn more:
• www.beljanski.org (https://www.beljanski.org/)
• www.maisonbeljanski.com (https://www.maisonbeljanski.com/)
